JL

James Loch

FT Forma Therapeutics: 6 patents #44 of 86Top 55%
AA Astrazeneca Ab: 2 patents #673 of 1,971Top 35%
EP E-Therapeutics Plc: 1 patents #4 of 17Top 25%
MP Madrigal Pharmaceuticals: 1 patents #25 of 40Top 65%
Overall (All Time): #502,087 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
10995078 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, Wei Lu, Matthew W. Martin +3 more 2021-05-04
10828315 Targeted therapeutics Dinesh U. Chimmanamada, Weiwen Ying, Junyi Zhang, Teresa Kowalczyk-Przewloka, Jun Jiang +4 more 2020-11-10
10800750 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, Wei Lu, Matthew W. Martin +3 more 2020-10-13
10472342 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, Wei Lu, Matthew W. Martin +3 more 2019-11-12
10457655 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, Wei Lu, Matthew W. Martin +3 more 2019-10-29
10450251 Process for the preparation of 3-substituted cannabinoid compounds Vijaya Bhasker Gondi, Nicholas J. Holman, Steven J. Collier 2019-10-22
10450286 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, Wei Lu, Matthew W. Martin +3 more 2019-10-22
10399951 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, Wei Lu, Matthew W. Martin +3 more 2019-09-03
7196096 Substituted amines of spirofuropyridines useful in therapy George B. Mullen, Eifion Phillips 2007-03-27
6995167 Arylkylamine spirofuropyridines useful in therapy George B. Mullen, Eifion Phillips 2006-02-07